Analyze Diet
Journal of equine science2020; 31(4); 105-111; doi: 10.1294/jes.31.105

Optimal double-spin method for maximizing the concentration of platelets in equine platelet-rich plasma.

Abstract: This study optimized the double-spin conditions for preparing equine platelet-rich plasma (PRP): leukocyte-rich PRP (L-PRP) and leukocyte-poor PRP (P-PRP). Whole blood samples were centrifuged at various double-spin conditions. Both L-PRP and P-PRP were prepared at each stage, and complete blood counts and growth factor concentrations were compared. Samples centrifuged at 160 × 900 g, 160 × 2,000 g, and 400 × 2,000 g exhibited the highest platelet counts. P-PRP had significantly lower leukocyte and erythrocyte contents than L-PRP, especially at 400 × 2,000 g. No significant differences were observed in growth factor concentrations. Our data suggest that optimum L-PRP preparation should include centrifugation under the aforementioned conditions, whereas centrifugation at 400 × 2,000 g is optimal for P-PRP.
Publication Date: 2020-12-18 PubMed ID: 33376448PubMed Central: PMC7750641DOI: 10.1294/jes.31.105Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research is about a study that optimizes the preparation method for equine platelet-rich plasma (PRP) with a focus on the double-spin conditions to maximize platelet concentration. The study establishes optimal conditions for Leukocyte-rich (L-PRP) and Leukocyte-poor PRP (P-PRP).

Methodology and Procedures

  • The research commenced by taking whole blood samples and centrifuging them under a variety of double-spin conditions.
  • Both L-PRP and P-PRP were prepared under each set of conditions.
  • Complete blood counts and growth factor concentrations were then compared.

Findings and Observations

  • The research found that samples centrifuged at 160 × 900 g, 160 × 2,000 g, and 400 × 2,000 g had the highest platelet counts.
  • The study established that P-PRP had significantly lower leukocyte and erythrocyte contents than L-PRP, especially under the condition 400 × 2,000 g.
  • No significant differences were observed in regards to the concentrations of growth factors.

Suggestions and Conclusions

  • The data collected from the research suggests that the optimal preparation of L-PRP should include centrifugation under the conditions specified in the findings (160 × 900 g, 160 × 2,000 g, and 400 × 2,000 g).
  • The study concludes that to optimally prepare P-PRP, centrifugation at 400 × 2,000 g should be employed.

Cite This Article

APA
Fukuda K, Kuwano A, Kuroda T, Tamura N, Mita H, Okada Y, Kasashima Y. (2020). Optimal double-spin method for maximizing the concentration of platelets in equine platelet-rich plasma. J Equine Sci, 31(4), 105-111. https://doi.org/10.1294/jes.31.105

Publication

ISSN: 1340-3516
NlmUniqueID: 9503751
Country: Japan
Language: English
Volume: 31
Issue: 4
Pages: 105-111

Researcher Affiliations

Fukuda, Kentaro
  • Clinical Veterinary Medicine Division, Equine Research Institute, Japan Racing Association, Tochigi 329-0412, Japan.
Kuwano, Atsutoshi
  • Clinical Veterinary Medicine Division, Equine Research Institute, Japan Racing Association, Tochigi 329-0412, Japan.
Kuroda, Taisuke
  • Clinical Veterinary Medicine Division, Equine Research Institute, Japan Racing Association, Tochigi 329-0412, Japan.
Tamura, Norihisa
  • Clinical Veterinary Medicine Division, Equine Research Institute, Japan Racing Association, Tochigi 329-0412, Japan.
Mita, Hiroshi
  • Clinical Veterinary Medicine Division, Equine Research Institute, Japan Racing Association, Tochigi 329-0412, Japan.
Okada, Yuji
  • Racehorse Clinic, Miho Training Center, Japan Racing Association, Ibaraki 300-0493, Japan.
Kasashima, Yoshinori
  • Research Planning and Coordination Division, Equine Research Institute, Japan Racing Association, Tochigi 329-0412, Japan.

References

This article includes 28 references
  1. Alio JL, Rodriguez AE, Abdelghany AA, Oliveira RF. Autologous platelet-rich plasma eye drops for the treatment of post-LASIK chronic ocular surface syndrome. J. Ophthalmol. 2017: 2457620.
    pmc: PMC5742891pubmed: 29379652
  2. Bosch G, van Schie HTM, de Groot MW, Cadby JA, van de Lest CHA, Barneveld A, van Weeren PR. Effects of platelet-rich plasma on the quality of repair of mechanically induced core lesions in equine superficial digital flexor tendons: a placebo-controlled experimental study. J. Orthop. Res. 28: 211–217.
    pubmed: 19714688
  3. Boswell SG, Schnabel LV, Mohammed HO, Sundman EA, Minas T, Fortier LA. Increasing platelet concentrations in leukocyte-reduced platelet-rich plasma decrease collagen gene synthesis in tendons. Am. J. Sports Med. 42: 42–49.
    pubmed: 24136860
  4. Braun HJ, Kim HJ, Chu CR, Dragoo JL. The effect of platelet-rich plasma formulations and blood products on human synoviocytes: implications for intra-articular injury and therapy. Am. J. Sports Med. 42: 1204–1210.
    pmc: PMC5878923pubmed: 24634448
  5. Dhurat R, Sukesh M. Principles and methods of preparation of platelet-rich plasma: a review and author’s perspective. J. Cutan. Aesthet. Surg. 7: 189–197.
    pmc: PMC4338460pubmed: 25722595
  6. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 27: 158–167.
    pubmed: 19187989
  7. Everts PAM, Knape JTA, Weibrich G, Schönberger JPAM, Hoffmann J, Overdevest EP, Box HAM, van Zundert A. Platelet-rich plasma and platelet gel: a review. J. Extra Corpor. Technol. 38: 174–187.
    pmc: PMC4680757pubmed: 16921694
  8. Hammond JW, Hinton RY, Curl LA, Muriel JM, Lovering RM. Use of autologous platelet-rich plasma to treat muscle strain injuries. Am. J. Sports Med. 37: 1135–1142.
    pmc: PMC3523111pubmed: 19282509
  9. Hsu WK, Mishra A, Rodeo SR, Fu F, Terry MA, Randelli P, Canale ST, Kelly FB. Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment. J. Am. Acad. Orthop. Surg. 21: 739–748.
    pubmed: 24292930
  10. Iacopetti I, Perazzi A, Ferrari V, Busetto R. Application of platelet-rich gel to enhance wound healing in the horse: a case report. J. Equine Vet. Sci. 32: 123–128.
  11. Jee CH, Eom NY, Jang HM, Jung HW, Choi ES, Won JH, Hong IH, Kang BT, Jeong DW, Jung DI. Effect of autologous platelet-rich plasma application on cutaneous wound healing in dogs. J. Vet. Sci. 17: 79–87.
    pmc: PMC4808647pubmed: 27051343
  12. Kim JH, Park C, Park HM. Curative effect of autologous platelet-rich plasma on a large cutaneous lesion in a dog. Vet. Dermatol. 20: 123–126.
    pubmed: 19159413
  13. King W, van der Weegen W, Van Drumpt R, Soons H, Toler K, Woodell-May J. White blood cell concentration correlates with increased concentrations of IL-1ra and improvement in WOMAC pain scores in an open-label safety study of autologous protein solution. J. Exp. Orthop. 3: 9.
    pmc: PMC4747972pubmed: 26915009
  14. Kisiday JD, McIlwraith CW, Rodkey WG, Frisbie DD, Steadman JR. Effects of platelet-rich plasma composition on anabolic and catabolic activities in equine cartilage and meniscal explants. Cartilage 3: 245–254.
    pmc: PMC4297115pubmed: 26069637
  15. Lana JFSD, Purita J, Paulus C, Huber SC, Rodrigues BL, Rodrigues AA, Santana MH, Madureira JL Jr, Malheiros Luzo ÂC, Belangero WD, Annichino-Bizzacchi JM. Contributions for classification of platelet rich plasma—proposal of a new classification: MARSPILL. Regen. Med. 12: 565–574.
    pubmed: 28758836
  16. Lee EB, Kim JW, Seo JP. Comparison of the methods for platelet rich plasma preparation in horses. J. Anim. Sci. Technol. 60: 20.
    pmc: PMC6098823pubmed: 30147942
  17. Magalon J, Chateau AL, Bertrand B, Louis ML, Silvestre A, Giraudo L, Veran J, Sabatier F. DEPA classification: a proposal for standardising PRP use and a retrospective application of available devices. BMJ Open Sport Exerc. Med. 2: e000060.
    pmc: PMC5117023pubmed: 27900152
  18. Marx RE. Platelet-rich plasma: evidence to support its use. J. Oral Maxillofac. Surg. 62: 489–496.
    pubmed: 15085519
  19. Mei-Dan O, Lippi G, Sánchez M, Andia I, Maffulli N. Autologous platelet-rich plasma: a revolution in soft tissue sports injury management?. Phys. Sportsmed. 38: 127–135.
    pubmed: 21150152
  20. Shin HS, Woo HM, Kang BJ. Optimisation of a double-centrifugation method for preparation of canine platelet-rich plasma. BMC Vet. Res. 13: 198.
    pmc: PMC5485745pubmed: 28651609
  21. Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am. J. Sports Med. 39: 2135–2140.
    pubmed: 21846925
  22. Sutter WW, Kaneps AJ, Bertone AL. Comparison of hematologic values and transforming growth factor-β and insulin-like growth factor concentrations in platelet concentrates obtained by use of buffy coat and apheresis methods from equine blood. Am. J. Vet. Res. 65: 924–930.
    pubmed: 15281650
  23. Tambella AM, Martin S, Cantalamessa A, Serri E, Attili AR. Platelet-rich plasma and other hemocomponents in veterinary regenerative medicine. Wounds 30: 329–336.
    pubmed: 30418162
  24. Textor JA, Norris JW, Tablin F. Effects of preparation method, shear force, and exposure to collagen on release of growth factors from equine platelet-rich plasma. Am. J. Vet. Res. 72: 271–278.
    pubmed: 21281204
  25. Vasconcelos E, Figueiredo AC, Seghatchian J. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis. Transfus. Apheresis Sci. 29: 13–16.
    pubmed: 12877887
  26. Waselau M, Sutter WW, Genovese RL, Bertone AL. Intralesional injection of platelet-rich plasma followed by controlled exercise for treatment of midbody suspensory ligament desmitis in Standardbred racehorses. J. Am. Vet. Med. Assoc. 232: 1515–1520.
    pubmed: 18479242
  27. Xie X, Zhao S, Wu H, Xie G, Huangfu X, He Y, Zhao J. Platelet-rich plasma enhances autograft revascularization and reinnervation in a dog model of anterior cruciate ligament reconstruction. J. Surg. Res. 183: 214–222.
    pubmed: 23472861
  28. Yin W, Xu H, Sheng J, Zhu Z, Jin D, Hsu P, Xie X, Zhang C. Optimization of pure platelet-rich plasma preparation: a comparative study of pure platelet-rich plasma obtained using different centrifugal conditions in a single-donor model. Exp. Ther. Med. 14: 2060–2070.
    pmc: PMC5609150pubmed: 28962125

Citations

This article has been cited 2 times.
  1. Reis IL, Lopes B, Sousa P, Sousa AC, Caseiro AR, Mendonça CM, Santos JM, Atayde LM, Alvites RD, Maurício AC. Equine Musculoskeletal Pathologies: Clinical Approaches and Therapeutical Perspectives-A Review. Vet Sci 2024 Apr 26;11(5).
    doi: 10.3390/vetsci11050190pubmed: 38787162google scholar: lookup
  2. Zheng JS, Liu SL, Peng XJ, Liu XF, Yu L, Liang SQ. [A prospective study of the effect and mechanism of autologous platelet-rich plasma combined with Meek microskin grafts in repairing the wounds of limbs in severely burned patients]. Zhonghua Shao Shang Za Zhi 2021 Aug 20;37(8):731-737.